Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90B1 | P14625 | 3/20 | 0.73 |
| ▸ | AHCY | P23526 | 11/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.56 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22799589 | 1.00 | HSP90B1 (0.73) | HSP90B1AHCYHIF1ATMEM97SIGMAR1 | |
| SCHEMBL8104706 | 0.85 | HSP90B1 (1.00) | HSP90B1AHCYHIF1ATMEM97SIGMAR1 | |
| SCHEMBL10883419 | 0.83 | HSP90B1 (0.85) | HSP90B1AHCYHIF1ATMEM97SIGMAR1 | |
| SCHEMBL11202311 | 0.83 | HSP90B1 (0.85) | HSP90B1AHCYHIF1ATMEM97SIGMAR1 | |
| SCHEMBL24673732 | 0.81 | HSP90B1 (0.58) | HSP90B1AHCYADORA2BADORA2AADORA3 | |
| SCHEMBL22797654 | 0.81 | HSP90B1 (0.71) | HSP90B1AHCYHIF1ATMEM97SIGMAR1 | |
| SCHEMBL24673147 | 0.81 | HSP90B1 (0.71) | HSP90B1AHCYHIF1ATMEM97SIGMAR1 | |
| SCHEMBL22797658 | 0.81 | HSP90B1 (0.71) | HSP90B1AHCYHIF1ATMEM97SIGMAR1 | |
| SCHEMBL7898363 | 0.80 | HSP90B1 (0.70) | HSP90B1AHCYHIF1ATMEM97SIGMAR1 | |
| SCHEMBL11407218 | 0.80 | HSP90B1 (0.70) | HSP90B1AHCYHIF1ATMEM97SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220275018-A1 | NOVEL SPIROBICYCLIC INTERMEDIATES | JANSSEN PHARMACEUTICA NV (BE) | 2022-09-01 | — | — | US | disclosed |
| WO-2020249663-A1 | NOVEL SPIROBICYCLIC INTERMEDIATES | JANSSEN PHARMACEUTICA NV (BE) | 2020-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220275018-A1 | NOVEL SPIROBICYCLIC INTERMEDIATES | NME2, SLC28A1, SLC28A2 | HSP90B1 567/4885AHCY 998/4885HIF1A 4479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.